RBCM
Raub Brock Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243K | Hold |
600
| – | – | 0.05% | 36 |
|
|
2025
Q1 | $299K | Hold |
600
| – | – | 0.07% | 36 |
|
|
2024
Q4 | $312K | Hold |
600
| – | – | 0.07% | 36 |
|
|
2024
Q3 | $371K | Hold |
600
| – | – | 0.08% | 34 |
|
|
2024
Q2 | $332K | Hold |
600
| – | – | 0.07% | 35 |
|
|
2024
Q1 | $349K | Hold |
600
| – | – | 0.07% | 35 |
|
|
2023
Q4 | $318K | Hold |
600
| – | – | 0.07% | 56 |
|
|
2023
Q3 | $304K | Hold |
600
| – | – | 0.06% | 53 |
|
|
2023
Q2 | $313K | Hold |
600
| – | – | 0.06% | 53 |
|
|
2023
Q1 | $346K | Hold |
600
| – | – | 0.07% | 50 |
|
|
2022
Q4 | $330K | Hold |
600
| – | – | 0.07% | 47 |
|
|
2022
Q3 | $304K | Hold |
600
| – | – | 0.06% | 49 |
|
|
2022
Q2 | $326K | Hold |
600
| – | – | 0.06% | 47 |
|
|
2022
Q1 | $354K | Buy |
+600
| New | +$354K | 0.06% | 51 |
|